MADALYN CHAUMONT: Open Payments
NPI 1295307221 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,147 in 104 payments from 14 companies in 2025. Trend: 2023 $2,829 · 2024 $2,878 · 2025 $2,147
Food & beverage: $2,137Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $473 |
| Janssen Biotech, Inc. | 19 | $451 |
| Intercept Pharmaceuticals, Inc. | 7 | $223 |
| Ardelyx, Inc. | 7 | $214 |
| Gilead Sciences, Inc. | 8 | $176 |
| Ipsen Biopharmaceuticals, Inc | 3 | $166 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $113 |
| QOL Medical, LLC | 5 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 6 | $50 |
Products named: TREMFYA, OCALIVA, IBSRELA, IQIRVO, RINVOQ, CREON, SKYRIZI, Sucraid.
Industry payments across LA — which companies pay providers there.
